544 related articles for article (PubMed ID: 29306476)
1. The CHA
Beyer-Westendorf J; Kreutz R; Posch F; Ay C
Int J Cardiol; 2018 Feb; 253():71-77. PubMed ID: 29306476
[TBL] [Abstract][Full Text] [Related]
2. Longitudinal kidney function trajectories predict major bleeding, hospitalization and death in patients with atrial fibrillation and chronic kidney disease.
Posch F; Ay C; Stöger H; Kreutz R; Beyer-Westendorf J
Int J Cardiol; 2019 May; 282():47-52. PubMed ID: 30777405
[TBL] [Abstract][Full Text] [Related]
3. Renal function after repeat catheter ablation for long-standing persistent atrial fibrillation : Low CHA2DS2-VASc score and sinus rhythm predict improved renal function.
Wang Q; Zhang XD; Liu X; Yang YQ
Herz; 2016 Jun; 41(4):331-41. PubMed ID: 26809454
[TBL] [Abstract][Full Text] [Related]
4. Aspirin and renal insufficiency progression in patients with atrial fibrillation and chronic kidney disease.
Pastori D; Pignatelli P; Perticone F; Sciacqua A; Carnevale R; Farcomeni A; Basili S; Corazza GR; Davì G; Lip GYH; Violi F;
Int J Cardiol; 2016 Nov; 223():619-624. PubMed ID: 27565838
[TBL] [Abstract][Full Text] [Related]
5. Competitive interaction between chronic obstructive pulmonary disease and CHA
Perticone M; Sciacqua A; Tripepi G; Miceli S; Corrao S; Sesti G; Perticone F
Int J Cardiol; 2018 Mar; 255():74-79. PubMed ID: 29174184
[TBL] [Abstract][Full Text] [Related]
6. Renal function and outcomes after catheter ablation of patients with atrial fibrillation: The Guangzhou atrial fibrillation ablation registry.
Deng H; Shantsila A; Xue Y; Bai Y; Guo P; Potpara TS; Zhan X; Fang X; Liao H; Wu S; Lip GYH
Arch Cardiovasc Dis; 2019; 112(6-7):420-429. PubMed ID: 31133543
[TBL] [Abstract][Full Text] [Related]
7. Usefulness of the Addition of Renal Function to the CHA2DS2-VASc Score as a Predictor of Thromboembolism and Mortality in Patients Without Atrial Fibrillation.
Parsons C; Cha S; Shen WK; Chamberlain AM; Luis SA; Keddis M; Shamoun F
Am J Cardiol; 2018 Aug; 122(4):597-603. PubMed ID: 29970238
[TBL] [Abstract][Full Text] [Related]
8. Prevalence of renal dysfunction according to the type of atrial fibrillation and anticoagulation treatment in patients who attended primary care in Spain.
Barrios V; Escobar C; Calderón A; Zamorano JL
Future Cardiol; 2014 Mar; 10(2):215-20. PubMed ID: 24762248
[TBL] [Abstract][Full Text] [Related]
9. Comparison of atrial fibrillation in CKD and non-CKD populations: A cross-sectional analysis from the Kailuan study.
Guo Y; Gao J; Ye P; Xing A; Wu Y; Wu S; Luo Y
Int J Cardiol; 2019 Feb; 277():125-129. PubMed ID: 30473335
[TBL] [Abstract][Full Text] [Related]
10. Relation of red cell distribution width with CHA2DS2-VASc score in patients with nonvalvular atrial fibrillation.
Kurt M; Tanboga IH; Buyukkaya E; Karakas MF; Akçay AB; Sen N
Clin Appl Thromb Hemost; 2014 Oct; 20(7):687-92. PubMed ID: 23430929
[TBL] [Abstract][Full Text] [Related]
11. Incidence and prediction of ischemic stroke among atrial fibrillation patients with end-stage renal disease requiring dialysis.
Chao TF; Liu CJ; Wang KL; Lin YJ; Chang SL; Lo LW; Hu YF; Tuan TC; Chung FP; Liao JN; Chen TJ; Lip GY; Chen SA
Heart Rhythm; 2014 Oct; 11(10):1752-9. PubMed ID: 24952148
[TBL] [Abstract][Full Text] [Related]
12. The impact of risk score (CHADS2 versus CHA2DS2-VASc) on long-term outcomes after atrial fibrillation ablation.
Jacobs V; May HT; Bair TL; Crandall BG; Cutler M; Day JD; Weiss JP; Osborn JS; Muhlestein JB; Anderson JL; Mallender C; Bunch TJ
Heart Rhythm; 2015 Apr; 12(4):681-6. PubMed ID: 25546809
[TBL] [Abstract][Full Text] [Related]
13. Associations of atrial fibrillation with renal function decline in patients with chronic kidney disease.
Chen TH; Chu YC; Ou SM; Tarng DC
Heart; 2022 Mar; 108(6):438-444. PubMed ID: 34193464
[TBL] [Abstract][Full Text] [Related]
14. The value of the CHA2DS2-VASc score for refining stroke risk stratification in patients with atrial fibrillation with a CHADS2 score 0-1: a nationwide cohort study.
Olesen JB; Torp-Pedersen C; Hansen ML; Lip GY
Thromb Haemost; 2012 Jun; 107(6):1172-9. PubMed ID: 22473219
[TBL] [Abstract][Full Text] [Related]
15. Assessment of the CHA2DS2-VASc Score in Predicting Ischemic Stroke, Thromboembolism, and Death in Patients With Heart Failure With and Without Atrial Fibrillation.
Melgaard L; Gorst-Rasmussen A; Lane DA; Rasmussen LH; Larsen TB; Lip GY
JAMA; 2015 Sep; 314(10):1030-8. PubMed ID: 26318604
[TBL] [Abstract][Full Text] [Related]
16. Renal dysfunction and the risk of postoperative atrial fibrillation after cardiac surgery: role beyond the CHA2DS2-VASc score.
Chua SK; Shyu KG; Lu MJ; Hung HF; Cheng JJ; Chiu CZ; Lin CH; Chao HH; Lo HM
Europace; 2015 Sep; 17(9):1363-70. PubMed ID: 25662985
[TBL] [Abstract][Full Text] [Related]
17. Does chronic kidney disease improve the predictive value of the CHADS2 and CHA2DS2-VASc stroke stratification risk scores for atrial fibrillation?
Roldán V; Marín F; Manzano-Fernandez S; Fernández H; Gallego P; Valdés M; Vicente V; Lip GY
Thromb Haemost; 2013 May; 109(5):956-60. PubMed ID: 23572113
[TBL] [Abstract][Full Text] [Related]
18. Improvement in estimated glomerular filtration rate in patients with chronic kidney disease undergoing catheter ablation for atrial fibrillation.
Navaravong L; Barakat M; Burgon N; Mahnkopf C; Koopmann M; Ranjan R; Kholmovski E; Marrouche N; Akoum N
J Cardiovasc Electrophysiol; 2015 Jan; 26(1):21-7. PubMed ID: 25142836
[TBL] [Abstract][Full Text] [Related]
19. CHA
Hu WS; Lin CL
Int J Cardiol; 2017 May; 235():56-60. PubMed ID: 28262350
[TBL] [Abstract][Full Text] [Related]
20. CHA2DS2-VASc score for ischaemic stroke risk stratification in patients with chronic obstructive pulmonary disease with and without atrial fibrillation: a nationwide cohort study.
Hu WS; Lin CL
Europace; 2018 Apr; 20(4):575-581. PubMed ID: 28407109
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
